This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.
"synopsis" may belong to another edition of this title.
Cong-Qiu Chu, MD, PhD is associate professor of medicine at Oregon Health & Science University and VA Portland Health Care System, Portland, Oregon. Dr Chu obtained his MD from Normal Bethune University of Medical Sciences, Changchun, China and PhD from the Kennedy Institute of Rheumatology, University of London, London, UK; completed his internal medicine residency at Peking Union Medical College Hospital, Beijing and Wayne State University Detroit Medical Center, Detroit, Michigan and rheumatology fellowship at University of Washington, Seattle. Dr Chu has a career long interest in the pathogenesis of rheumatoid arthritis (RA). His seminal observation that tumor necrosis factor (TNF) is over-expressed in RA joint tissue helped the development of TNF inhibitors for therapy of RA. His contribution was recognized by European League Against Rheumatism Young Investigator Award in 1991. Dr Chu is one of the investigators who first demonstrated that T helper type 1 (Th1) cells are not the cell types mediating autoimmune inflammatory diseases, which were later uncovered to be mediated by Th17 cells. Dr Chu’s current research includes developing novel therapeutic strategies using RNA interference technology for precise targeting Th17 cells for inflammatory diseases and developing optimal management strategies for early RA.
"About this title" may belong to another edition of this title.
£ 27.52 shipping from U.S.A. to United Kingdom
Destination, rates & speeds£ 9.59 shipping from Germany to United Kingdom
Destination, rates & speedsSeller: BEAR'S BOOK FOREST, SYRACUSE, NY, U.S.A.
Soft cover. Condition: Very Good. 1st Edition. Seller Inventory # ABE-1574559722255
Quantity: 2 available
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals. 120 pp. Englisch. Seller Inventory # 9783319280394
Quantity: 2 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals. Seller Inventory # 9783319280394
Quantity: 1 available
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A comprehensive overview of the role of IL-17/Th17 in inflammatory disorders and discussion of the latest therapeutic advances targeting this pathwayIncludes the latest evidence-based treatment recommendations based on the most up-to-date research and c. Seller Inventory # 101774150
Quantity: Over 20 available
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand pp. 120. Seller Inventory # 385540476
Quantity: 4 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 120. Seller Inventory # 26378363555
Quantity: 4 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND pp. 120. Seller Inventory # 18378363561
Quantity: 4 available
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 102 pages. 7.75x5.00x0.25 inches. In Stock. Seller Inventory # 3319280392
Quantity: 1 available
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. Neuware -This book provides an overview of the discovery and structure of IL-17, including its pathogenesis and role in chronic inflammation and autoimmunity. To capture the latest developments and product approvals the book also discusses the therapeutic advances and looks at emerging therapies targeting the IL-17 pathway. IL-17 is a pro-inflammatory cytokine that has a key role in inflammation, autoimmunity, and host defense in a number of inflammatory disorders such as rheumatoid arthritis, psoriatic arthritis and psoriasis, ankylosing spondylitis, multiple sclerosis, and inflammatory bowel disease. The discovery of the IL-17-Th17 pathway has seen exciting development in the field of immunology and inflammation research, which has led to a number of recent regulatory approvals.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 120 pp. Englisch. Seller Inventory # 9783319280394
Quantity: 2 available
Seller: HPB-Red, Dallas, TX, U.S.A.
paperback. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Seller Inventory # S_446250243
Quantity: 1 available